Recent advances in the understanding of immune function and the interactions with tumour
cells have led to the development of various cancer immunotherapies and strategies for …

Simple Summary Outcomes of ovarian cancer (OC) patients remain poor despite recent
advances in oncology. Immunotherapy has proven to be beneficial in treating selected …

Breast cancer is one of the most human malignant diseases and the leading cause of cancer-
related death in the world. However, the prognostic and therapeutic benefits of breast cancer …

As one of the most common gynecologic malignant tumors, ovarian cancer is usually
diagnosed at an advanced and incurable stage because of its early asymptomatic onset …

Accurate and rapid diagnosis of malignant pleural and peritoneal effusions is critical due to
potential association with advanced disease stages or progression. Traditional …

(1) Background: Biomarkers might play a significant role in predicting the clinical outcomes
of patients with ovarian cancer. By analyzing lipid metabolism genes, future perspectives …

Extracellular vesicles (EVs) secreted from tumor-associated macrophages (TAMs) are
known to generate an immune-suppressive environment conducive to the development of …

Background Colorectal cancer is the second leading cause of cancer-related deaths, which
imposes a significant societal burden. Regular screening and emerging molecular tumor …

Ovarian cancer is the eighth most commonly diagnosed cancer among women worldwide.
Even with the development of novel drugs, nearly one-half of the patients with ovarian …

Targeted gene therapy has shown durable efficacy in non-neoplastic and neoplastic
patients. Therefore, finding a suitable target has become a key area of research …